Baseline characteristics by affected coronary vessels at the coronary angiogram.
. | Numbers . | All patients . | Normal . | 1-vessel (excl. LM) . | 2-vessel (excl. LM) . | 3-vessel (excl. LM) . | Left main stem (LM) . | p-Value . |
---|---|---|---|---|---|---|---|---|
Angiographic findings %, (n) | 2776 | 20.9 (580) | 23.1 (641) | 18.1 (503) | 29.4 (815) | 8.5 (237) | < 0.001 | |
Clinical characteristics | ||||||||
Age, years, mean, (range), SD | 2776 | 58 (19–88) SD 11 | 53 (19–86) SD 11 | 56 (25–86) SD 11 | 58 (32–85) SD 10 | 60 (34–85) SD 10 | 63 (37–88) SD 10 | <0.001 |
Male, %, (n) | 2776 | 58.4 (1621) | 53.3 (309) | 58.5 (375) | 56.3 (283) | 60.5 (493) | 67.9 (161) | 0.002 |
BMI, kg/m2, mean, (range), SD | 2360 | 26.4 (15.4–74.5) SD 4.4 | 26.8 (16.9–74.5) SD 5.3 | 26.5 (17.3–52.8) SD 4.3 | 26.5 (16.9–43.5) SD 4.2 | 26.2 (15.4 –42.5) SD 4.2 | 26.1 (16.2–40.3) SD 4.1 | 0.137 |
Smoker, current, %, (n) | 2254 | 15.0 (339) | 14.3 (64) | 16.9 (98) | 19.0 (80) | 13.2 (82) | 8.3 (15) | <0.001 |
Systolic blood pressure, mm Hg, mean, (range), SD | 2575 | 136 (84–220) SD 18 | 134 (84–200) SD 18 | 136 (90–214) SD 18 | 136 (90–210) SD 17 | 138 (85–220) SD18 | 137 (100–190) SD 17 | 0.001 |
Diastolic blood pressure, mm Hg, mean, (range), SD | 2575 | 73 (40–115) SD 10 | 74 (40–105) SD 10 | 73 (50–115) SD10 | 74 (48–110) SD 10 | 72 (40–108) SD 10 | 71 (40–102) SD 10 | <0.001 |
Hypertension, treated, %, (n) | 2639 | 80.4 (2121) | 68.7 (375) | 80.3 (480) | 82.6 (398) | 85.5 (671) | 86.4 (197) | <0.001 |
Antihypertensive medication, %, (n) | 2766 | 80.5 (2236) | 82.9 (481) | 79.7 (511) | 80.5 (405) | 79.4 (647) | 81.0 (192) | 0.788 |
Hyperlipidaemia, treated, %, (n) | 2247 | 68.0 (1528) | 60.4 (271) | 62.2 (361) | 69.9 (290) | 74.4 (462) | 79.4 (143) | <0.001 |
Atrial fibrillation, %, (n) | 2776 | 5.2 (144) | 6.9 (40) | 4.2 (27) | 3.0 (15) | 5.6 (46) | 6.8 (16) | 0.025 |
Previous disease, %, (n) | ||||||||
Myocardialinfarction | 2776 | 38.5 (1069) | 15.9 (92) | 33.2 (213) | 42.5 (214) | 51.2 (417) | 56.1 (133) | <0.001 |
Any CAD | 2776 | 58.0 (1610) | 31.6 (183) | 52.6 (337) | 63.6 (320) | 72.3 (589) | 76.4 (181) | <0.001 |
Previous PCI | 2617 | 5.8 (153) | 2.6 (14) | 5.7 (35) | 7.1 (34) | 7.4 (56) | 6.3 (14) | 0.022 |
Previous CABG | 2776 | 10.5 (291) | 1.2 (7) | 3.0 (19) | 5.0 (25) | 21.3 (174) | 27.8 (66) | <0.001 |
Previous angina | 2776 | 35.4 (982) | 19.8 (115) | 28.7 (184) | 35.6 (179) | 47.5 (387) | 49.4 (117) | <0.001 |
Heart failure | 2776 | 14.9 (414) | 11.4 (66) | 7.8 (50) | 13.5 (68) | 21.1 (172) | 24.5 (58) | <0.001 |
Stroke | 2776 | 8.3 (231) | 5.7 (33) | 6.2 (40) | 8.5 (43) | 9.9 (81) | 14.3 (34) | <0.001 |
Renal insufficiency | 2776 | 11.0 (306) | 12.9 (75) | 9.7 (62) | 11.7 (59) | 11.0 (90) | 8.4 (20) | 0.266 |
Peripheral artery diseasea | 2776 | 16.3 (452) | 9.1 (53) | 10.5 (67) | 17.5 (88) | 22.3 (182) | 26.2 (62) | <0.001 |
Diabetes-related variables | ||||||||
HbA1c, mmol/mol, mean, (range), SD | 2638 | 66.7 (26–145) SD 14.1 | 65.6 (29–123) SD 14.8 | 66.8 (26–145) SD 14.3 | 67.4 (28–130) SD 13.7 | 67.2 (33–133) SD 13.5 | 65.7 (33–110) SD 13.9 | 0.162 |
Diabetes duration, years, mean, (range), SD | 2776 | 35 (0–76) SD 14 | 29 (0–76) SD 14 | 33 (0–69) SD 14 | 35 (0–73) SD 14 | 39 (5–70) SD 13 | 42 (8–75) SD 14 | <0.001 |
Debute age, years, mean, (range), SD | 2776 | 23 (0–50) SD 13 | 24 (0–50) SD 14 | 23 (1–50) SD 13 | 23 (0–50) SD 13 | 21 (1–50) SD 13 | 22 (0–50) SD 14 | 0.001 |
Creatinine, µmol/l, mean, (range), SD | 2524 | 121 (24–1013) SD 128 | 140 (34–1013) SD 177 | 113 (24–938) SD 114 | 118 (37–872) SD 117 | 117 (40–971) SD 107 | 114 (45–761) SD 96 | 0.003 |
LDL, mg/dl, mean, (range), SD | 1840 | 2.7 (0.5–7.3) SD 0.9 | 2.6 (0.6–6.0) SD 0.8 | 2.7 (0.9–7.3) SD 0.9 | 2.7 (0.5–7.3) SD 0.9 | 2.7 (0.6–6.0) SD 0.9 | 2.7 (0.7–7.0) SD 0.9 | 0.275 |
HDL, mg/dl, mean, (range), SD | 1861 | 1.52 (0.43–3.97) SD 0.49 | 1.60 (0.43–3.8) SD 0.52 | 1.53 (0.60–3.40) SD 0.48 | 1.46 (0.52–2.80) SD 0.45 | 1.52 (0.64–3.97) SD 0.50 | 1.45 (0.59–3.56) SD 0.48 | 0.002 |
Triglycerides, mg/dl, mean, (range), SD | 1859 | 1.39 (0.30–14.10) SD 1.02 | 1.27 (0.30–9.60) SD 0.87 | 1.44 (0.38–11.20), SD 1.11 | 1.47 (0.30–10.0) SD1.02 | 1.40 (0.40–13.0) SD 0.96 | 1.43 (0.40–14.10) SD 1.27 | 0.064 |
Retinopathy, %, (n) | 2776 | 66.1 (1836) | 60.0 (348) | 63.8 (409) | 65.8 (331) | 71.2 (580) | 70.9 (168) | <0.001 |
Never hypo-glycaemia, %, (n) | 596 | 89.8 (535) | 90.6 (126) | 93.8 (151) | 89.7 (96) | 85.0 (119) | 87.8 (43) | 0.121 |
Pump, %, (n) | 2033 | 12.2 (248) | 17.6 (77) | 12.0 (59) | 9.7 (35) | 12.3 (71) | 3.6 (6) | <0.001 |
Never physical activity, %, (n) | 1378 | 15.2 (209) | 12.9 (38) | 14.2 (50) | 14.2 (33) | 17.5 (68) | 18.5 (20) | 0.255 |
Micro albuminuria, %, (n) | 2276 | 46.8 (1065) | 40.1 (190) | 42.7 (223) | 49.9 (205) | 51.0 (346) | 52.9 (101) | <0.001 |
Macro albuminuria, %, (n) | 2318 | 23.5 (544) | 23.4 (110) | 20.6 (109) | 24.6 (103) | 24.3 (169) | 25.7 (53) | 0.478 |
Angio indication, %, (n) | 2752 | <0.001 | ||||||
Stable | 31.3 (862) | 22.6 (129) | 27.7 (177) | 30.8 (154) | 38.7 (311) | 38.4 (91) | ||
NSTE-ACS | 37.5 (1032) | 23.8 (136) | 37.2 (238) | 41.2 (206) | 42.3 (340) | 47.3 (112) | ||
STEMI | 10.2 (280) | 2.1 (12) | 17.7 (113) | 12.8 (64) | 9.6 (77) | 5.9 (14) | ||
Chest pain | 5.4 (135) | 19.1 (109) | 1.7 (11) | 1.6 (8) | 0.7 (6) | 0.4 (1) | ||
Silent IHD | 2.9 (81) | 4.2 (24) | 2.7 (17) | 3.6 (18) | 2.4 (19) | 1.3 (3) | ||
Arrhythmia | 1.3 (36) | 4.5 (26) | 0.6 (4) | 0.6 (3) | 0.2 (2) | 0.4 (1) | ||
Valvular | 3.6 (98) | 8.0 (46) | 4.2 (27) | 2.4 (12) | 1.0 (8) | 2.1 (5) | ||
Heart failure | 3.6 (100) | 7.5 (43) | 2.8 (18) | 2.8 (14) | 2.5 (20) | 2.1 (5) | ||
Aorta aneurysm | 0 (1) | 0.2 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
Cardiac arrest | 0.4 (10) | 0.5 (3) | 0.3 (2) | 0.4 (2) | 0.2 (2) | 0.4 (1) | ||
Stent | ||||||||
Numbers, mean, (range), SD | 993 | 1.2 (0–5) SD 0.9 | 0.3 (0–3) SD 0.7 | 1.1 (0–4) SD 0.7 | 1.3 (0–4) SD 0.9 | 1.3 (0–5) SD 1.1 | 1.3 (0–5) SD 1.3 | <0.001 |
Complete revascularisation after PCI, %, (n) | 876 | 58.8 (515) | 77.8 (7) | 90.2 (360) | 40.6 (103) | 20.7 (36) | 22.5 (9) | <0.001 |
Primary decision after angiography, %, (n) | 2698 | <0.001 | ||||||
No therapy | 9.7 (263) | 38.8 (222) | 3.2 (20) | 1.6 (8) | 1.1 (9) | 1.8 (4) | ||
Medical | 19.5 (525) | 39.7 (227) | 15.6 (98) | 11.1 (54) | 14.8 (116) | 13.2 (30) | ||
CABG | 19.8 (535) | 0 (0) | 1.4 (9) | 11.3 (55) | 44.1 (346) | 55.1 (125) | ||
PCI | 36.2 (976) | 3.8 (22) | 68.6 (430) | 58.2 (284) | 25.3 (198) | 18.5 (42) |
. | Numbers . | All patients . | Normal . | 1-vessel (excl. LM) . | 2-vessel (excl. LM) . | 3-vessel (excl. LM) . | Left main stem (LM) . | p-Value . |
---|---|---|---|---|---|---|---|---|
Angiographic findings %, (n) | 2776 | 20.9 (580) | 23.1 (641) | 18.1 (503) | 29.4 (815) | 8.5 (237) | < 0.001 | |
Clinical characteristics | ||||||||
Age, years, mean, (range), SD | 2776 | 58 (19–88) SD 11 | 53 (19–86) SD 11 | 56 (25–86) SD 11 | 58 (32–85) SD 10 | 60 (34–85) SD 10 | 63 (37–88) SD 10 | <0.001 |
Male, %, (n) | 2776 | 58.4 (1621) | 53.3 (309) | 58.5 (375) | 56.3 (283) | 60.5 (493) | 67.9 (161) | 0.002 |
BMI, kg/m2, mean, (range), SD | 2360 | 26.4 (15.4–74.5) SD 4.4 | 26.8 (16.9–74.5) SD 5.3 | 26.5 (17.3–52.8) SD 4.3 | 26.5 (16.9–43.5) SD 4.2 | 26.2 (15.4 –42.5) SD 4.2 | 26.1 (16.2–40.3) SD 4.1 | 0.137 |
Smoker, current, %, (n) | 2254 | 15.0 (339) | 14.3 (64) | 16.9 (98) | 19.0 (80) | 13.2 (82) | 8.3 (15) | <0.001 |
Systolic blood pressure, mm Hg, mean, (range), SD | 2575 | 136 (84–220) SD 18 | 134 (84–200) SD 18 | 136 (90–214) SD 18 | 136 (90–210) SD 17 | 138 (85–220) SD18 | 137 (100–190) SD 17 | 0.001 |
Diastolic blood pressure, mm Hg, mean, (range), SD | 2575 | 73 (40–115) SD 10 | 74 (40–105) SD 10 | 73 (50–115) SD10 | 74 (48–110) SD 10 | 72 (40–108) SD 10 | 71 (40–102) SD 10 | <0.001 |
Hypertension, treated, %, (n) | 2639 | 80.4 (2121) | 68.7 (375) | 80.3 (480) | 82.6 (398) | 85.5 (671) | 86.4 (197) | <0.001 |
Antihypertensive medication, %, (n) | 2766 | 80.5 (2236) | 82.9 (481) | 79.7 (511) | 80.5 (405) | 79.4 (647) | 81.0 (192) | 0.788 |
Hyperlipidaemia, treated, %, (n) | 2247 | 68.0 (1528) | 60.4 (271) | 62.2 (361) | 69.9 (290) | 74.4 (462) | 79.4 (143) | <0.001 |
Atrial fibrillation, %, (n) | 2776 | 5.2 (144) | 6.9 (40) | 4.2 (27) | 3.0 (15) | 5.6 (46) | 6.8 (16) | 0.025 |
Previous disease, %, (n) | ||||||||
Myocardialinfarction | 2776 | 38.5 (1069) | 15.9 (92) | 33.2 (213) | 42.5 (214) | 51.2 (417) | 56.1 (133) | <0.001 |
Any CAD | 2776 | 58.0 (1610) | 31.6 (183) | 52.6 (337) | 63.6 (320) | 72.3 (589) | 76.4 (181) | <0.001 |
Previous PCI | 2617 | 5.8 (153) | 2.6 (14) | 5.7 (35) | 7.1 (34) | 7.4 (56) | 6.3 (14) | 0.022 |
Previous CABG | 2776 | 10.5 (291) | 1.2 (7) | 3.0 (19) | 5.0 (25) | 21.3 (174) | 27.8 (66) | <0.001 |
Previous angina | 2776 | 35.4 (982) | 19.8 (115) | 28.7 (184) | 35.6 (179) | 47.5 (387) | 49.4 (117) | <0.001 |
Heart failure | 2776 | 14.9 (414) | 11.4 (66) | 7.8 (50) | 13.5 (68) | 21.1 (172) | 24.5 (58) | <0.001 |
Stroke | 2776 | 8.3 (231) | 5.7 (33) | 6.2 (40) | 8.5 (43) | 9.9 (81) | 14.3 (34) | <0.001 |
Renal insufficiency | 2776 | 11.0 (306) | 12.9 (75) | 9.7 (62) | 11.7 (59) | 11.0 (90) | 8.4 (20) | 0.266 |
Peripheral artery diseasea | 2776 | 16.3 (452) | 9.1 (53) | 10.5 (67) | 17.5 (88) | 22.3 (182) | 26.2 (62) | <0.001 |
Diabetes-related variables | ||||||||
HbA1c, mmol/mol, mean, (range), SD | 2638 | 66.7 (26–145) SD 14.1 | 65.6 (29–123) SD 14.8 | 66.8 (26–145) SD 14.3 | 67.4 (28–130) SD 13.7 | 67.2 (33–133) SD 13.5 | 65.7 (33–110) SD 13.9 | 0.162 |
Diabetes duration, years, mean, (range), SD | 2776 | 35 (0–76) SD 14 | 29 (0–76) SD 14 | 33 (0–69) SD 14 | 35 (0–73) SD 14 | 39 (5–70) SD 13 | 42 (8–75) SD 14 | <0.001 |
Debute age, years, mean, (range), SD | 2776 | 23 (0–50) SD 13 | 24 (0–50) SD 14 | 23 (1–50) SD 13 | 23 (0–50) SD 13 | 21 (1–50) SD 13 | 22 (0–50) SD 14 | 0.001 |
Creatinine, µmol/l, mean, (range), SD | 2524 | 121 (24–1013) SD 128 | 140 (34–1013) SD 177 | 113 (24–938) SD 114 | 118 (37–872) SD 117 | 117 (40–971) SD 107 | 114 (45–761) SD 96 | 0.003 |
LDL, mg/dl, mean, (range), SD | 1840 | 2.7 (0.5–7.3) SD 0.9 | 2.6 (0.6–6.0) SD 0.8 | 2.7 (0.9–7.3) SD 0.9 | 2.7 (0.5–7.3) SD 0.9 | 2.7 (0.6–6.0) SD 0.9 | 2.7 (0.7–7.0) SD 0.9 | 0.275 |
HDL, mg/dl, mean, (range), SD | 1861 | 1.52 (0.43–3.97) SD 0.49 | 1.60 (0.43–3.8) SD 0.52 | 1.53 (0.60–3.40) SD 0.48 | 1.46 (0.52–2.80) SD 0.45 | 1.52 (0.64–3.97) SD 0.50 | 1.45 (0.59–3.56) SD 0.48 | 0.002 |
Triglycerides, mg/dl, mean, (range), SD | 1859 | 1.39 (0.30–14.10) SD 1.02 | 1.27 (0.30–9.60) SD 0.87 | 1.44 (0.38–11.20), SD 1.11 | 1.47 (0.30–10.0) SD1.02 | 1.40 (0.40–13.0) SD 0.96 | 1.43 (0.40–14.10) SD 1.27 | 0.064 |
Retinopathy, %, (n) | 2776 | 66.1 (1836) | 60.0 (348) | 63.8 (409) | 65.8 (331) | 71.2 (580) | 70.9 (168) | <0.001 |
Never hypo-glycaemia, %, (n) | 596 | 89.8 (535) | 90.6 (126) | 93.8 (151) | 89.7 (96) | 85.0 (119) | 87.8 (43) | 0.121 |
Pump, %, (n) | 2033 | 12.2 (248) | 17.6 (77) | 12.0 (59) | 9.7 (35) | 12.3 (71) | 3.6 (6) | <0.001 |
Never physical activity, %, (n) | 1378 | 15.2 (209) | 12.9 (38) | 14.2 (50) | 14.2 (33) | 17.5 (68) | 18.5 (20) | 0.255 |
Micro albuminuria, %, (n) | 2276 | 46.8 (1065) | 40.1 (190) | 42.7 (223) | 49.9 (205) | 51.0 (346) | 52.9 (101) | <0.001 |
Macro albuminuria, %, (n) | 2318 | 23.5 (544) | 23.4 (110) | 20.6 (109) | 24.6 (103) | 24.3 (169) | 25.7 (53) | 0.478 |
Angio indication, %, (n) | 2752 | <0.001 | ||||||
Stable | 31.3 (862) | 22.6 (129) | 27.7 (177) | 30.8 (154) | 38.7 (311) | 38.4 (91) | ||
NSTE-ACS | 37.5 (1032) | 23.8 (136) | 37.2 (238) | 41.2 (206) | 42.3 (340) | 47.3 (112) | ||
STEMI | 10.2 (280) | 2.1 (12) | 17.7 (113) | 12.8 (64) | 9.6 (77) | 5.9 (14) | ||
Chest pain | 5.4 (135) | 19.1 (109) | 1.7 (11) | 1.6 (8) | 0.7 (6) | 0.4 (1) | ||
Silent IHD | 2.9 (81) | 4.2 (24) | 2.7 (17) | 3.6 (18) | 2.4 (19) | 1.3 (3) | ||
Arrhythmia | 1.3 (36) | 4.5 (26) | 0.6 (4) | 0.6 (3) | 0.2 (2) | 0.4 (1) | ||
Valvular | 3.6 (98) | 8.0 (46) | 4.2 (27) | 2.4 (12) | 1.0 (8) | 2.1 (5) | ||
Heart failure | 3.6 (100) | 7.5 (43) | 2.8 (18) | 2.8 (14) | 2.5 (20) | 2.1 (5) | ||
Aorta aneurysm | 0 (1) | 0.2 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
Cardiac arrest | 0.4 (10) | 0.5 (3) | 0.3 (2) | 0.4 (2) | 0.2 (2) | 0.4 (1) | ||
Stent | ||||||||
Numbers, mean, (range), SD | 993 | 1.2 (0–5) SD 0.9 | 0.3 (0–3) SD 0.7 | 1.1 (0–4) SD 0.7 | 1.3 (0–4) SD 0.9 | 1.3 (0–5) SD 1.1 | 1.3 (0–5) SD 1.3 | <0.001 |
Complete revascularisation after PCI, %, (n) | 876 | 58.8 (515) | 77.8 (7) | 90.2 (360) | 40.6 (103) | 20.7 (36) | 22.5 (9) | <0.001 |
Primary decision after angiography, %, (n) | 2698 | <0.001 | ||||||
No therapy | 9.7 (263) | 38.8 (222) | 3.2 (20) | 1.6 (8) | 1.1 (9) | 1.8 (4) | ||
Medical | 19.5 (525) | 39.7 (227) | 15.6 (98) | 11.1 (54) | 14.8 (116) | 13.2 (30) | ||
CABG | 19.8 (535) | 0 (0) | 1.4 (9) | 11.3 (55) | 44.1 (346) | 55.1 (125) | ||
PCI | 36.2 (976) | 3.8 (22) | 68.6 (430) | 58.2 (284) | 25.3 (198) | 18.5 (42) |
BMI: body mass index; CAD: coronary artery disease; CABG: coronary artery bypass graft; HbA1c: glycated haemoglobin; IHD: ischaemic heart disease; LM: left main-vessel disease; LDL: low density lipoprotein; HDL: high density lipoprotein; NSTE-ACS: non-ST-elevation acute coronary syndrome; PCI: percutaneous coronary intervention; SD: standard deviation; STEMI: ST-elevation myocardial infarction.
Hospitalisation for.
Baseline characteristics by affected coronary vessels at the coronary angiogram.
. | Numbers . | All patients . | Normal . | 1-vessel (excl. LM) . | 2-vessel (excl. LM) . | 3-vessel (excl. LM) . | Left main stem (LM) . | p-Value . |
---|---|---|---|---|---|---|---|---|
Angiographic findings %, (n) | 2776 | 20.9 (580) | 23.1 (641) | 18.1 (503) | 29.4 (815) | 8.5 (237) | < 0.001 | |
Clinical characteristics | ||||||||
Age, years, mean, (range), SD | 2776 | 58 (19–88) SD 11 | 53 (19–86) SD 11 | 56 (25–86) SD 11 | 58 (32–85) SD 10 | 60 (34–85) SD 10 | 63 (37–88) SD 10 | <0.001 |
Male, %, (n) | 2776 | 58.4 (1621) | 53.3 (309) | 58.5 (375) | 56.3 (283) | 60.5 (493) | 67.9 (161) | 0.002 |
BMI, kg/m2, mean, (range), SD | 2360 | 26.4 (15.4–74.5) SD 4.4 | 26.8 (16.9–74.5) SD 5.3 | 26.5 (17.3–52.8) SD 4.3 | 26.5 (16.9–43.5) SD 4.2 | 26.2 (15.4 –42.5) SD 4.2 | 26.1 (16.2–40.3) SD 4.1 | 0.137 |
Smoker, current, %, (n) | 2254 | 15.0 (339) | 14.3 (64) | 16.9 (98) | 19.0 (80) | 13.2 (82) | 8.3 (15) | <0.001 |
Systolic blood pressure, mm Hg, mean, (range), SD | 2575 | 136 (84–220) SD 18 | 134 (84–200) SD 18 | 136 (90–214) SD 18 | 136 (90–210) SD 17 | 138 (85–220) SD18 | 137 (100–190) SD 17 | 0.001 |
Diastolic blood pressure, mm Hg, mean, (range), SD | 2575 | 73 (40–115) SD 10 | 74 (40–105) SD 10 | 73 (50–115) SD10 | 74 (48–110) SD 10 | 72 (40–108) SD 10 | 71 (40–102) SD 10 | <0.001 |
Hypertension, treated, %, (n) | 2639 | 80.4 (2121) | 68.7 (375) | 80.3 (480) | 82.6 (398) | 85.5 (671) | 86.4 (197) | <0.001 |
Antihypertensive medication, %, (n) | 2766 | 80.5 (2236) | 82.9 (481) | 79.7 (511) | 80.5 (405) | 79.4 (647) | 81.0 (192) | 0.788 |
Hyperlipidaemia, treated, %, (n) | 2247 | 68.0 (1528) | 60.4 (271) | 62.2 (361) | 69.9 (290) | 74.4 (462) | 79.4 (143) | <0.001 |
Atrial fibrillation, %, (n) | 2776 | 5.2 (144) | 6.9 (40) | 4.2 (27) | 3.0 (15) | 5.6 (46) | 6.8 (16) | 0.025 |
Previous disease, %, (n) | ||||||||
Myocardialinfarction | 2776 | 38.5 (1069) | 15.9 (92) | 33.2 (213) | 42.5 (214) | 51.2 (417) | 56.1 (133) | <0.001 |
Any CAD | 2776 | 58.0 (1610) | 31.6 (183) | 52.6 (337) | 63.6 (320) | 72.3 (589) | 76.4 (181) | <0.001 |
Previous PCI | 2617 | 5.8 (153) | 2.6 (14) | 5.7 (35) | 7.1 (34) | 7.4 (56) | 6.3 (14) | 0.022 |
Previous CABG | 2776 | 10.5 (291) | 1.2 (7) | 3.0 (19) | 5.0 (25) | 21.3 (174) | 27.8 (66) | <0.001 |
Previous angina | 2776 | 35.4 (982) | 19.8 (115) | 28.7 (184) | 35.6 (179) | 47.5 (387) | 49.4 (117) | <0.001 |
Heart failure | 2776 | 14.9 (414) | 11.4 (66) | 7.8 (50) | 13.5 (68) | 21.1 (172) | 24.5 (58) | <0.001 |
Stroke | 2776 | 8.3 (231) | 5.7 (33) | 6.2 (40) | 8.5 (43) | 9.9 (81) | 14.3 (34) | <0.001 |
Renal insufficiency | 2776 | 11.0 (306) | 12.9 (75) | 9.7 (62) | 11.7 (59) | 11.0 (90) | 8.4 (20) | 0.266 |
Peripheral artery diseasea | 2776 | 16.3 (452) | 9.1 (53) | 10.5 (67) | 17.5 (88) | 22.3 (182) | 26.2 (62) | <0.001 |
Diabetes-related variables | ||||||||
HbA1c, mmol/mol, mean, (range), SD | 2638 | 66.7 (26–145) SD 14.1 | 65.6 (29–123) SD 14.8 | 66.8 (26–145) SD 14.3 | 67.4 (28–130) SD 13.7 | 67.2 (33–133) SD 13.5 | 65.7 (33–110) SD 13.9 | 0.162 |
Diabetes duration, years, mean, (range), SD | 2776 | 35 (0–76) SD 14 | 29 (0–76) SD 14 | 33 (0–69) SD 14 | 35 (0–73) SD 14 | 39 (5–70) SD 13 | 42 (8–75) SD 14 | <0.001 |
Debute age, years, mean, (range), SD | 2776 | 23 (0–50) SD 13 | 24 (0–50) SD 14 | 23 (1–50) SD 13 | 23 (0–50) SD 13 | 21 (1–50) SD 13 | 22 (0–50) SD 14 | 0.001 |
Creatinine, µmol/l, mean, (range), SD | 2524 | 121 (24–1013) SD 128 | 140 (34–1013) SD 177 | 113 (24–938) SD 114 | 118 (37–872) SD 117 | 117 (40–971) SD 107 | 114 (45–761) SD 96 | 0.003 |
LDL, mg/dl, mean, (range), SD | 1840 | 2.7 (0.5–7.3) SD 0.9 | 2.6 (0.6–6.0) SD 0.8 | 2.7 (0.9–7.3) SD 0.9 | 2.7 (0.5–7.3) SD 0.9 | 2.7 (0.6–6.0) SD 0.9 | 2.7 (0.7–7.0) SD 0.9 | 0.275 |
HDL, mg/dl, mean, (range), SD | 1861 | 1.52 (0.43–3.97) SD 0.49 | 1.60 (0.43–3.8) SD 0.52 | 1.53 (0.60–3.40) SD 0.48 | 1.46 (0.52–2.80) SD 0.45 | 1.52 (0.64–3.97) SD 0.50 | 1.45 (0.59–3.56) SD 0.48 | 0.002 |
Triglycerides, mg/dl, mean, (range), SD | 1859 | 1.39 (0.30–14.10) SD 1.02 | 1.27 (0.30–9.60) SD 0.87 | 1.44 (0.38–11.20), SD 1.11 | 1.47 (0.30–10.0) SD1.02 | 1.40 (0.40–13.0) SD 0.96 | 1.43 (0.40–14.10) SD 1.27 | 0.064 |
Retinopathy, %, (n) | 2776 | 66.1 (1836) | 60.0 (348) | 63.8 (409) | 65.8 (331) | 71.2 (580) | 70.9 (168) | <0.001 |
Never hypo-glycaemia, %, (n) | 596 | 89.8 (535) | 90.6 (126) | 93.8 (151) | 89.7 (96) | 85.0 (119) | 87.8 (43) | 0.121 |
Pump, %, (n) | 2033 | 12.2 (248) | 17.6 (77) | 12.0 (59) | 9.7 (35) | 12.3 (71) | 3.6 (6) | <0.001 |
Never physical activity, %, (n) | 1378 | 15.2 (209) | 12.9 (38) | 14.2 (50) | 14.2 (33) | 17.5 (68) | 18.5 (20) | 0.255 |
Micro albuminuria, %, (n) | 2276 | 46.8 (1065) | 40.1 (190) | 42.7 (223) | 49.9 (205) | 51.0 (346) | 52.9 (101) | <0.001 |
Macro albuminuria, %, (n) | 2318 | 23.5 (544) | 23.4 (110) | 20.6 (109) | 24.6 (103) | 24.3 (169) | 25.7 (53) | 0.478 |
Angio indication, %, (n) | 2752 | <0.001 | ||||||
Stable | 31.3 (862) | 22.6 (129) | 27.7 (177) | 30.8 (154) | 38.7 (311) | 38.4 (91) | ||
NSTE-ACS | 37.5 (1032) | 23.8 (136) | 37.2 (238) | 41.2 (206) | 42.3 (340) | 47.3 (112) | ||
STEMI | 10.2 (280) | 2.1 (12) | 17.7 (113) | 12.8 (64) | 9.6 (77) | 5.9 (14) | ||
Chest pain | 5.4 (135) | 19.1 (109) | 1.7 (11) | 1.6 (8) | 0.7 (6) | 0.4 (1) | ||
Silent IHD | 2.9 (81) | 4.2 (24) | 2.7 (17) | 3.6 (18) | 2.4 (19) | 1.3 (3) | ||
Arrhythmia | 1.3 (36) | 4.5 (26) | 0.6 (4) | 0.6 (3) | 0.2 (2) | 0.4 (1) | ||
Valvular | 3.6 (98) | 8.0 (46) | 4.2 (27) | 2.4 (12) | 1.0 (8) | 2.1 (5) | ||
Heart failure | 3.6 (100) | 7.5 (43) | 2.8 (18) | 2.8 (14) | 2.5 (20) | 2.1 (5) | ||
Aorta aneurysm | 0 (1) | 0.2 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
Cardiac arrest | 0.4 (10) | 0.5 (3) | 0.3 (2) | 0.4 (2) | 0.2 (2) | 0.4 (1) | ||
Stent | ||||||||
Numbers, mean, (range), SD | 993 | 1.2 (0–5) SD 0.9 | 0.3 (0–3) SD 0.7 | 1.1 (0–4) SD 0.7 | 1.3 (0–4) SD 0.9 | 1.3 (0–5) SD 1.1 | 1.3 (0–5) SD 1.3 | <0.001 |
Complete revascularisation after PCI, %, (n) | 876 | 58.8 (515) | 77.8 (7) | 90.2 (360) | 40.6 (103) | 20.7 (36) | 22.5 (9) | <0.001 |
Primary decision after angiography, %, (n) | 2698 | <0.001 | ||||||
No therapy | 9.7 (263) | 38.8 (222) | 3.2 (20) | 1.6 (8) | 1.1 (9) | 1.8 (4) | ||
Medical | 19.5 (525) | 39.7 (227) | 15.6 (98) | 11.1 (54) | 14.8 (116) | 13.2 (30) | ||
CABG | 19.8 (535) | 0 (0) | 1.4 (9) | 11.3 (55) | 44.1 (346) | 55.1 (125) | ||
PCI | 36.2 (976) | 3.8 (22) | 68.6 (430) | 58.2 (284) | 25.3 (198) | 18.5 (42) |
. | Numbers . | All patients . | Normal . | 1-vessel (excl. LM) . | 2-vessel (excl. LM) . | 3-vessel (excl. LM) . | Left main stem (LM) . | p-Value . |
---|---|---|---|---|---|---|---|---|
Angiographic findings %, (n) | 2776 | 20.9 (580) | 23.1 (641) | 18.1 (503) | 29.4 (815) | 8.5 (237) | < 0.001 | |
Clinical characteristics | ||||||||
Age, years, mean, (range), SD | 2776 | 58 (19–88) SD 11 | 53 (19–86) SD 11 | 56 (25–86) SD 11 | 58 (32–85) SD 10 | 60 (34–85) SD 10 | 63 (37–88) SD 10 | <0.001 |
Male, %, (n) | 2776 | 58.4 (1621) | 53.3 (309) | 58.5 (375) | 56.3 (283) | 60.5 (493) | 67.9 (161) | 0.002 |
BMI, kg/m2, mean, (range), SD | 2360 | 26.4 (15.4–74.5) SD 4.4 | 26.8 (16.9–74.5) SD 5.3 | 26.5 (17.3–52.8) SD 4.3 | 26.5 (16.9–43.5) SD 4.2 | 26.2 (15.4 –42.5) SD 4.2 | 26.1 (16.2–40.3) SD 4.1 | 0.137 |
Smoker, current, %, (n) | 2254 | 15.0 (339) | 14.3 (64) | 16.9 (98) | 19.0 (80) | 13.2 (82) | 8.3 (15) | <0.001 |
Systolic blood pressure, mm Hg, mean, (range), SD | 2575 | 136 (84–220) SD 18 | 134 (84–200) SD 18 | 136 (90–214) SD 18 | 136 (90–210) SD 17 | 138 (85–220) SD18 | 137 (100–190) SD 17 | 0.001 |
Diastolic blood pressure, mm Hg, mean, (range), SD | 2575 | 73 (40–115) SD 10 | 74 (40–105) SD 10 | 73 (50–115) SD10 | 74 (48–110) SD 10 | 72 (40–108) SD 10 | 71 (40–102) SD 10 | <0.001 |
Hypertension, treated, %, (n) | 2639 | 80.4 (2121) | 68.7 (375) | 80.3 (480) | 82.6 (398) | 85.5 (671) | 86.4 (197) | <0.001 |
Antihypertensive medication, %, (n) | 2766 | 80.5 (2236) | 82.9 (481) | 79.7 (511) | 80.5 (405) | 79.4 (647) | 81.0 (192) | 0.788 |
Hyperlipidaemia, treated, %, (n) | 2247 | 68.0 (1528) | 60.4 (271) | 62.2 (361) | 69.9 (290) | 74.4 (462) | 79.4 (143) | <0.001 |
Atrial fibrillation, %, (n) | 2776 | 5.2 (144) | 6.9 (40) | 4.2 (27) | 3.0 (15) | 5.6 (46) | 6.8 (16) | 0.025 |
Previous disease, %, (n) | ||||||||
Myocardialinfarction | 2776 | 38.5 (1069) | 15.9 (92) | 33.2 (213) | 42.5 (214) | 51.2 (417) | 56.1 (133) | <0.001 |
Any CAD | 2776 | 58.0 (1610) | 31.6 (183) | 52.6 (337) | 63.6 (320) | 72.3 (589) | 76.4 (181) | <0.001 |
Previous PCI | 2617 | 5.8 (153) | 2.6 (14) | 5.7 (35) | 7.1 (34) | 7.4 (56) | 6.3 (14) | 0.022 |
Previous CABG | 2776 | 10.5 (291) | 1.2 (7) | 3.0 (19) | 5.0 (25) | 21.3 (174) | 27.8 (66) | <0.001 |
Previous angina | 2776 | 35.4 (982) | 19.8 (115) | 28.7 (184) | 35.6 (179) | 47.5 (387) | 49.4 (117) | <0.001 |
Heart failure | 2776 | 14.9 (414) | 11.4 (66) | 7.8 (50) | 13.5 (68) | 21.1 (172) | 24.5 (58) | <0.001 |
Stroke | 2776 | 8.3 (231) | 5.7 (33) | 6.2 (40) | 8.5 (43) | 9.9 (81) | 14.3 (34) | <0.001 |
Renal insufficiency | 2776 | 11.0 (306) | 12.9 (75) | 9.7 (62) | 11.7 (59) | 11.0 (90) | 8.4 (20) | 0.266 |
Peripheral artery diseasea | 2776 | 16.3 (452) | 9.1 (53) | 10.5 (67) | 17.5 (88) | 22.3 (182) | 26.2 (62) | <0.001 |
Diabetes-related variables | ||||||||
HbA1c, mmol/mol, mean, (range), SD | 2638 | 66.7 (26–145) SD 14.1 | 65.6 (29–123) SD 14.8 | 66.8 (26–145) SD 14.3 | 67.4 (28–130) SD 13.7 | 67.2 (33–133) SD 13.5 | 65.7 (33–110) SD 13.9 | 0.162 |
Diabetes duration, years, mean, (range), SD | 2776 | 35 (0–76) SD 14 | 29 (0–76) SD 14 | 33 (0–69) SD 14 | 35 (0–73) SD 14 | 39 (5–70) SD 13 | 42 (8–75) SD 14 | <0.001 |
Debute age, years, mean, (range), SD | 2776 | 23 (0–50) SD 13 | 24 (0–50) SD 14 | 23 (1–50) SD 13 | 23 (0–50) SD 13 | 21 (1–50) SD 13 | 22 (0–50) SD 14 | 0.001 |
Creatinine, µmol/l, mean, (range), SD | 2524 | 121 (24–1013) SD 128 | 140 (34–1013) SD 177 | 113 (24–938) SD 114 | 118 (37–872) SD 117 | 117 (40–971) SD 107 | 114 (45–761) SD 96 | 0.003 |
LDL, mg/dl, mean, (range), SD | 1840 | 2.7 (0.5–7.3) SD 0.9 | 2.6 (0.6–6.0) SD 0.8 | 2.7 (0.9–7.3) SD 0.9 | 2.7 (0.5–7.3) SD 0.9 | 2.7 (0.6–6.0) SD 0.9 | 2.7 (0.7–7.0) SD 0.9 | 0.275 |
HDL, mg/dl, mean, (range), SD | 1861 | 1.52 (0.43–3.97) SD 0.49 | 1.60 (0.43–3.8) SD 0.52 | 1.53 (0.60–3.40) SD 0.48 | 1.46 (0.52–2.80) SD 0.45 | 1.52 (0.64–3.97) SD 0.50 | 1.45 (0.59–3.56) SD 0.48 | 0.002 |
Triglycerides, mg/dl, mean, (range), SD | 1859 | 1.39 (0.30–14.10) SD 1.02 | 1.27 (0.30–9.60) SD 0.87 | 1.44 (0.38–11.20), SD 1.11 | 1.47 (0.30–10.0) SD1.02 | 1.40 (0.40–13.0) SD 0.96 | 1.43 (0.40–14.10) SD 1.27 | 0.064 |
Retinopathy, %, (n) | 2776 | 66.1 (1836) | 60.0 (348) | 63.8 (409) | 65.8 (331) | 71.2 (580) | 70.9 (168) | <0.001 |
Never hypo-glycaemia, %, (n) | 596 | 89.8 (535) | 90.6 (126) | 93.8 (151) | 89.7 (96) | 85.0 (119) | 87.8 (43) | 0.121 |
Pump, %, (n) | 2033 | 12.2 (248) | 17.6 (77) | 12.0 (59) | 9.7 (35) | 12.3 (71) | 3.6 (6) | <0.001 |
Never physical activity, %, (n) | 1378 | 15.2 (209) | 12.9 (38) | 14.2 (50) | 14.2 (33) | 17.5 (68) | 18.5 (20) | 0.255 |
Micro albuminuria, %, (n) | 2276 | 46.8 (1065) | 40.1 (190) | 42.7 (223) | 49.9 (205) | 51.0 (346) | 52.9 (101) | <0.001 |
Macro albuminuria, %, (n) | 2318 | 23.5 (544) | 23.4 (110) | 20.6 (109) | 24.6 (103) | 24.3 (169) | 25.7 (53) | 0.478 |
Angio indication, %, (n) | 2752 | <0.001 | ||||||
Stable | 31.3 (862) | 22.6 (129) | 27.7 (177) | 30.8 (154) | 38.7 (311) | 38.4 (91) | ||
NSTE-ACS | 37.5 (1032) | 23.8 (136) | 37.2 (238) | 41.2 (206) | 42.3 (340) | 47.3 (112) | ||
STEMI | 10.2 (280) | 2.1 (12) | 17.7 (113) | 12.8 (64) | 9.6 (77) | 5.9 (14) | ||
Chest pain | 5.4 (135) | 19.1 (109) | 1.7 (11) | 1.6 (8) | 0.7 (6) | 0.4 (1) | ||
Silent IHD | 2.9 (81) | 4.2 (24) | 2.7 (17) | 3.6 (18) | 2.4 (19) | 1.3 (3) | ||
Arrhythmia | 1.3 (36) | 4.5 (26) | 0.6 (4) | 0.6 (3) | 0.2 (2) | 0.4 (1) | ||
Valvular | 3.6 (98) | 8.0 (46) | 4.2 (27) | 2.4 (12) | 1.0 (8) | 2.1 (5) | ||
Heart failure | 3.6 (100) | 7.5 (43) | 2.8 (18) | 2.8 (14) | 2.5 (20) | 2.1 (5) | ||
Aorta aneurysm | 0 (1) | 0.2 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
Cardiac arrest | 0.4 (10) | 0.5 (3) | 0.3 (2) | 0.4 (2) | 0.2 (2) | 0.4 (1) | ||
Stent | ||||||||
Numbers, mean, (range), SD | 993 | 1.2 (0–5) SD 0.9 | 0.3 (0–3) SD 0.7 | 1.1 (0–4) SD 0.7 | 1.3 (0–4) SD 0.9 | 1.3 (0–5) SD 1.1 | 1.3 (0–5) SD 1.3 | <0.001 |
Complete revascularisation after PCI, %, (n) | 876 | 58.8 (515) | 77.8 (7) | 90.2 (360) | 40.6 (103) | 20.7 (36) | 22.5 (9) | <0.001 |
Primary decision after angiography, %, (n) | 2698 | <0.001 | ||||||
No therapy | 9.7 (263) | 38.8 (222) | 3.2 (20) | 1.6 (8) | 1.1 (9) | 1.8 (4) | ||
Medical | 19.5 (525) | 39.7 (227) | 15.6 (98) | 11.1 (54) | 14.8 (116) | 13.2 (30) | ||
CABG | 19.8 (535) | 0 (0) | 1.4 (9) | 11.3 (55) | 44.1 (346) | 55.1 (125) | ||
PCI | 36.2 (976) | 3.8 (22) | 68.6 (430) | 58.2 (284) | 25.3 (198) | 18.5 (42) |
BMI: body mass index; CAD: coronary artery disease; CABG: coronary artery bypass graft; HbA1c: glycated haemoglobin; IHD: ischaemic heart disease; LM: left main-vessel disease; LDL: low density lipoprotein; HDL: high density lipoprotein; NSTE-ACS: non-ST-elevation acute coronary syndrome; PCI: percutaneous coronary intervention; SD: standard deviation; STEMI: ST-elevation myocardial infarction.
Hospitalisation for.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.